CompletedPhase 4

Emdogain Implementation With Transcrestal Sinus Lifting and Dental Implant Placement

Turkey (Türkiye)24 participantsStarted 2017-01

Plain-language summary

The aim of this study is to evaluate the clinical and radiographic results of implants placed using osteotome sinus ﬂoor elevation (OSFE) with and without simultaneous enamel matrix derivative (EMD) application.

Who can participate

Age range

18 Years – 99 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * partial edentulism in the maxillary posterior region for at least 4 months from tooth loss and require implant treatment * adequate bone thickness for primary stabilization * residual bone height ranged from 4 mm to 6 mm * systemic and local conditions compatible with implant placement and sinus ﬂoor elevation * antagonist teeth Exclusion Criteria: * uncontrolled diabetes mellitus or other systemic disorders (such as; hepatitis, tuberculosis, AIDS) * pregnancy * untreated periodontal disease * endodontic lesions or other oral disorders * heavy smokers (≥10 cigarettes per day) * acute or chronic rhinitis * sinusitis or pathology in sinus * inadequate residual bone height and quality to achieve implant stability * previous implant treatment/failure or bone augmentation in the implant site * sinus perforation as confirmed via Valsalva maneuver * insufficient primary implant stability measured by RFA

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

endo-sinus bone gain

Timeframe: CBCT will be evaluated at initiation of study (T0), at 3th month (T1) and 12th month (T2)

Trial details

NCT IDNCT05507047

SponsorT.C. Dumlupınar Üniversitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01

View on ClinicalTrials.gov More Osseointegration Failure of Dental Implant trials

Who can participate

Age range

18 Years – 99 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.